Files and links (2)
A systematic review - Cost-effectiveness of continuous glucose monitoring compared to self-monitoring of blood glucose in type 1 diabetes859.91 kB
Published VersionCC BY V4.0, Open Access
Journal article
A systematic review: Cost-effectiveness of continuous glucose monitoring compared to self-monitoring of blood glucose in type 1 diabetes
Endocrinology, Diabetes & Metabolism, Vol.5(6), pp.1-12
2022
PMID: 36112608
Abstract
Continuous glucose monitoring (CGM) is rapidly becoming a vital tool in the management of type 1 diabetes. Its use has been shown to improve glycaemic management and reduce the risk of hypoglycaemic events. The cost of CGM remains a barrier to its widespread application. We aimed to identify and synthesize evidence about the cost-effectiveness of utilizing CGM in patients with type 1 diabetes. Studies were identified from MEDLINE, Embase and Cochrane Library from January 2010 to February 2022. Those that assessed the cost-effectiveness of CGM compared to self-monitored blood glucose (SMBG) in patients with type 1 diabetes and reported lifetime incremental cost-effectiveness ratio (ICER) were included. Studies on critically ill or pregnant patients were excluded. Nineteen studies were identified. Most studies compared continuous subcutaneous insulin infusion and SMBG to a sensor-augmented pump (SAP). The estimated ICER range was [$18,734– $99,941] and the quality-adjusted life year (QALY) gain range was [0.76– 2.99]. Use in patients with suboptimal management or greater hypoglycaemic risk revealed more homogenous results and lower ICERs. Limited studies assessed CGM in the context of multiple daily injections (MDI) (n = 4), MDI and SMBG versus SAP (n = 2) and three studies included hybrid closed-loop systems. Most studies (n = 17) concluded that CGM is a cost-effective tool. This systematic review suggests that CGM appears to be a cost-effective tool for individuals with type 1 diabetes. Cost-effectiveness is driven by reducing short-and long-term complications. Use in patients with suboptimal management or at risk of severe hypoglycaemia is most cost-effective.
Details
- Title
- A systematic review: Cost-effectiveness of continuous glucose monitoring compared to self-monitoring of blood glucose in type 1 diabetes
- Authors
- Yuxin Jiao (Author) - Austin HealthRose Lin (Author) - Austin HealthXinyang Hua (Author) - The University of MelbourneLeonid Churilov (Author) - The University of MelbourneMichele J Gaca (Author) - Austin HealthSteven James (Author) - University of the Sunshine Coast, Queensland, School of Nursing, Midwifery and Paramedicine - LegacyPhilip M Clarke (Author) - University of OxfordDavid O'Neal (Author) - The University of MelbourneElif I Ekinci (Corresponding Author) - Austin Health
- Publication details
- Endocrinology, Diabetes & Metabolism, Vol.5(6), pp.1-12
- Publisher
- John Wiley & Sons
- Date published
- 2022
- DOI
- 10.1002/edm2.369
- ISSN
- 2398-9238
- PMID
- 36112608
- Copyright note
- © 2022 The Authors. Endocrinology, Diabetes & Metabolism published by John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
- Organisation Unit
- School of Health - Nursing; University of the Sunshine Coast, Queensland; School of Nursing, Midwifery and Paramedicine - Legacy
- Language
- English
- Record Identifier
- 99677498802621
- Output Type
- Journal article
Metrics
4 File views/ downloads
92 Record Views
InCites Highlights
These are selected metrics from InCites Benchmarking & Analytics tool, related to this output
- Collaboration types
- Domestic collaboration
- International collaboration
- Web Of Science research areas
- Endocrinology & Metabolism
UN Sustainable Development Goals (SDGs)
This output has contributed to the advancement of the following goals:
Source: InCites